Cynata Therapeutics Limited (ASX:CYP) Secures $8.1 Million Placement
Cynata Therapeutics raises $8.1 million following positive DFU trial results.
Cynata Therapeutics raises $8.1 million following positive DFU trial results.
CleanSpace Holdings (ASX:CSX) announces Gabrielle O’Carroll as new CEO to drive growth in the respiratory technology sector.
Tuas Limited reports positive Q1 FY25 results and strong growth in mobile services at their AGM.
Forbidden Foods Limited (ASX:FFF) reports a remarkable 80% increase in sales for November 2024, reaching over $500,000.
Acrux Limited (ASX:ACR) updates its investor presentation following FDA approval and capital raising efforts.
Audeara Ltd (ASX:AUA) raises $1.35 million through a strategic placement to drive growth in its AUA Technology division.
Farm Pride Foods Ltd reports lifting of quarantine, resuming normal operations at Lethbridge farms impacted by Avian Influenza.
Cynata Therapeutics (ASX:CYP) reports successful outcomes from its CYP-006TK clinical trial for diabetic foot ulcers, highlighting safety and efficacy.
CLINUVEL’s Chairman reflects on operational achievements and outlines strategic objectives for the upcoming year.
Aumake Limited (ASX: AUK) announces the successful completion of its first trial shipments under a procurement framework with Yangtze River SOE.